Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients.

MLA

Vaidya, Anil, et al. “Cost-Effectiveness of Risk Assessment and Tailored Treatment for Peripheral Arterial Disease Patients.” Biomarkers in Medicine, vol. 8, no. 8, Aug. 2014, pp. 989–99. EBSCOhost, https://doi.org/10.2217/bmm.14.45.

APA

Vaidya, A., Joore, M. A., ten Cate-Hoek, A. J., Cate, H. ten, & Severens, J. L. (2014). Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients. Biomarkers in Medicine, 8(8), 989–999. https://doi.org/10.2217/bmm.14.45

Chicago

Vaidya, Anil, Manuela A Joore, Arina J ten Cate-Hoek, Hugo ten Cate, and Johan L Severens. 2014. “Cost-Effectiveness of Risk Assessment and Tailored Treatment for Peripheral Arterial Disease Patients.” Biomarkers in Medicine 8 (8): 989–99. doi:10.2217/bmm.14.45.